These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 31514254)
1. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate. Bagheri Nejad R; Yahyaraeyat R; Es-Haghi A; Nayeri Fasaei B; Zahraei Salehi T APMIS; 2019 Dec; 127(12):797-804. PubMed ID: 31514254 [TBL] [Abstract][Full Text] [Related]
2. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302 [TBL] [Abstract][Full Text] [Related]
3. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice. Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738 [TBL] [Abstract][Full Text] [Related]
4. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen. Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis. Al-Mariri A; Abbady AQ J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643 [TBL] [Abstract][Full Text] [Related]
6. Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice. Avila-Calderón ED; Lopez-Merino A; Jain N; Peralta H; López-Villegas EO; Sriranganathan N; Boyle SM; Witonsky S; Contreras-Rodríguez A Clin Dev Immunol; 2012; 2012():352493. PubMed ID: 22242036 [TBL] [Abstract][Full Text] [Related]
7. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Cassataro J; Velikovsky CA; de la Barrera S; Estein SM; Bruno L; Bowden R; Pasquevich KA; Fossati CA; Giambartolomei GH Infect Immun; 2005 Oct; 73(10):6537-46. PubMed ID: 16177328 [TBL] [Abstract][Full Text] [Related]
8. Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice. Jain-Gupta N; Contreras-Rodriguez A; Vemulapalli R; Witonsky SG; Boyle SM; Sriranganathan N FEMS Immunol Med Microbiol; 2012 Dec; 66(3):436-44. PubMed ID: 23163875 [TBL] [Abstract][Full Text] [Related]
9. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice. Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316 [TBL] [Abstract][Full Text] [Related]
10. Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein. Al-Mariri A Vaccine; 2010 Feb; 28(7):1766-70. PubMed ID: 20036752 [TBL] [Abstract][Full Text] [Related]
11. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy. Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutics to prevent the replication of Brucella in a treatment failure mouse model. Jain-Gupta N; Contreras-Rodriguez A; Smith GP; Garg VK; Witonsky SG; Isloor S; Vemulapalli R; Boyle SM; Sriranganathan N Vaccine; 2014 Feb; 32(8):918-23. PubMed ID: 24397905 [TBL] [Abstract][Full Text] [Related]
13. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881 [TBL] [Abstract][Full Text] [Related]
14. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats. Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541 [TBL] [Abstract][Full Text] [Related]
15. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection. Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754 [TBL] [Abstract][Full Text] [Related]
16. Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3. Hamdy ME; El-Gibaly SM; Montasser AM Vet Microbiol; 2002 Aug; 88(1):85-94. PubMed ID: 12119140 [TBL] [Abstract][Full Text] [Related]
17. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice. Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468 [TBL] [Abstract][Full Text] [Related]